{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:23:34Z","timestamp":1757618614017,"version":"3.44.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03176-w","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:49:15Z","timestamp":1752155355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radiation-induced acute pericarditis after palliative spine radiation in a non-small cell lung cancer patient on osimertinib: a case report"],"prefix":"10.1007","volume":"16","author":[{"given":"Chomkwan","family":"Decha-umphai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thitiwan","family":"Prachanukul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanthida","family":"Phattraprayoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teerapat","family":"Ungtrakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"10","key":"3176_CR1","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1080\/09553002.2021.1956007","volume":"97","author":"T Wei","year":"2021","unstructured":"Wei T, Cheng Y. The cardiac toxicity of radiotherapy - a review of characteristics, mechanisms, diagnosis, and prevention. Int J Radiat Biol. 2021;97(10):1333\u201340.","journal-title":"Int J Radiat Biol"},{"issue":"2","key":"3176_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3857\/roj.2021.00766","volume":"40","author":"S Ellahham","year":"2022","unstructured":"Ellahham S, Khalouf A, Elkhazendar M, Dababo N, Manla Y. An overview of radiation-induced heart disease. Radiat Oncol J. 2022;40(2):89\u2013102.","journal-title":"Radiat Oncol J"},{"issue":"4","key":"3176_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jnci.2015.07.005","volume":"27","author":"R Madan","year":"2015","unstructured":"Madan R, Benson R, Sharma DN, Julka PK, Rath GK. Radiation induced heart disease: pathogenesis, management and review literature. J Egypt Natl Canc Inst. 2015;27(4):187\u201393.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"9","key":"3176_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11886-019-1192-y","volume":"21","author":"N Szpakowski","year":"2019","unstructured":"Szpakowski N, Desai MY. Radiation-Associated pericardial disease. Curr Cardiol Rep. 2019;21(9):97.","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"3176_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11936-019-0726-3","volume":"21","author":"E Donnellan","year":"2019","unstructured":"Donnellan E, Jellis CL, Griffin BP. Radiation-Associated cardiac disease: from molecular mechanisms to clinical management. Curr Treat Options Cardiovasc Med. 2019;21(5):22.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"suppl1","key":"3176_CR6","doi-asserted-by":"publisher","first-page":"i20","DOI":"10.1093\/annonc\/mdx704","volume":"29","author":"J Remon","year":"2018","unstructured":"Remon J, Steuer CE, Ramalingam SS, Felip E. Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients. Ann Oncol. 2018;29(suppl1):i20\u20137.","journal-title":"Ann Oncol"},{"issue":"3","key":"3176_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","volume":"13","author":"R Rosell","year":"2012","unstructured":"Rosell R, Carcereny E, Gervais R, et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 2012;13(3):239\u201346.","journal-title":"Lancet Oncol"},{"key":"3176_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","volume":"62","author":"LH Schwartz","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E, et al. RECIST 1.1-Update and clarification: from the RECIST committee. Eur J Cancer. 2016;62:132\u20137.","journal-title":"Eur J Cancer"},{"issue":"11","key":"3176_CR9","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.annonc.2020.08.2100","volume":"31","author":"VA Papadimitrakopoulou","year":"2020","unstructured":"Papadimitrakopoulou VA, Mok TS, Han JY, et al. Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis. Ann Oncol. 2020;31(11):1536\u201344.","journal-title":"Ann Oncol"},{"issue":"20","key":"3176_CR10","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.3390\/cancers16203466","volume":"16","author":"L Lorenzo-Esteller","year":"2024","unstructured":"Lorenzo-Esteller L, Ramos-Polo R, Pons Riverola A, et al. Pericardial disease in patients with cancer: clinical insights on diagnosis and treatment. Cancers (Basel). 2024;16(20):3466.","journal-title":"Cancers (Basel)"},{"key":"3176_CR11","doi-asserted-by":"publisher","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) [published correction appears in Eur Heart J. 2023;44(18):1621. https:\/\/doi.org\/10.1093\/eurheartj\/ehad196]. Eur Heart J. 2022;43(41):4229\u20134361.","DOI":"10.1093\/eurheartj\/ehad196]"},{"issue":"42","key":"3176_CR12","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Y Adler","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European society of cardiology (ESC)Endorsed by: the European association for Cardio-Thoracic surgery (EACTS). Eur Heart J. 2015;36(42):2921\u201364.","journal-title":"Eur Heart J"},{"key":"3176_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.amjcard.2020.12.092","volume":"145","author":"J Chahine","year":"2021","unstructured":"Chahine J, Shekhar S, Mahalwar G, Imazio M, Collier P, Klein A. Pericardial involvement in Cancer. Am J Cardiol. 2021;145:151\u20139.","journal-title":"Am J Cardiol"},{"issue":"5","key":"3176_CR14","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3390\/jcm9051268","volume":"9","author":"M Zaborowska-Szmit","year":"2020","unstructured":"Zaborowska-Szmit M, Krzakowski M, Kowalski DM, Szmit S. Cardiovascular complications of systemic therapy in Non-Small-Cell lung Cancer. J Clin Med. 2020;9(5):1268.","journal-title":"J Clin Med"},{"issue":"2","key":"3176_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jaccao.2019.10.006","volume":"1","author":"K Anand","year":"2019","unstructured":"Anand K, Ensor J, Trachtenberg B, Bernicker EH. Osimertinib-Induced cardiotoxicity: A retrospective review of the FDA adverse events reporting system (FAERS). JACC CardioOncol. 2019;1(2):172\u20138.","journal-title":"JACC CardioOncol"},{"issue":"13","key":"3176_CR16","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","volume":"35","author":"K Wang","year":"2017","unstructured":"Wang K, Eblan MJ, Deal AM, et al. Cardiac toxicity after radiotherapy for stage III Non-Small-Cell lung cancer: pooled analysis of Dose-Escalation trials delivering 70 to 90 Gy. J Clin Oncol. 2017;35(13):1387\u201394.","journal-title":"J Clin Oncol"},{"key":"3176_CR17","doi-asserted-by":"publisher","first-page":"1431023","DOI":"10.3389\/fonc.2024.1431023","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Deng X, Qiu Q, Wan M. Risk factors of osimertinib-related cardiotoxicity in non-small cell lung cancer. Front Oncol. 2024;14:1431023.","journal-title":"Front Oncol"},{"key":"3176_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.radonc.2020.07.051","volume":"152","author":"W Jia","year":"2020","unstructured":"Jia W, Guo H, Jing W, et al. An especially high rate of radiation pneumonitis observed in patients treated with thoracic radiotherapy and simultaneous osimertinib. Radiother Oncol. 2020;152:96\u2013100.","journal-title":"Radiother Oncol"},{"issue":"1","key":"3176_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3892\/or.2020.7593","volume":"41","author":"N Wang","year":"2019","unstructured":"Wang N, Wang L, Meng X, et al. Osimertinib (AZD9291) increases radiosensitivity in EGFR T790M nonsmall cell lung cancer. Oncol Rep. 2019;41(1):77\u201386.","journal-title":"Oncol Rep"},{"issue":"13","key":"3176_CR20","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1001\/jama.2024.12935","volume":"332","author":"PC Cremer","year":"2024","unstructured":"Cremer PC, Klein AL, Imazio M, Diagnosis. Risk stratification, and treatment of pericarditis: A review. JAMA. 2024;332(13):1090\u2013100.","journal-title":"JAMA"},{"key":"3176_CR21","doi-asserted-by":"crossref","unstructured":"Belzile-Dugas E, Eisenberg MJ. Radiation-Induced Cardiovascular Disease: Review of an Underrecognized Pathology [published correction appears in J Am Heart Assoc. 2023;12(10):e027687. doi: 10.1161\/JAHA.121.027687]. J Am Heart Assoc. 2021;10(18):e021686.","DOI":"10.1161\/JAHA.121.021686"},{"issue":"5","key":"3176_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/jrr\/rrae068","volume":"65","author":"M Uehara","year":"2024","unstructured":"Uehara M, Bekki N, Shiga T. Radiation-associated cardiovascular disease in patients with cancer: current insights from a cardio-oncologist. J Radiat Res. 2024;65(5):575\u201390.","journal-title":"J Radiat Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03176-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03176-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03176-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:36:19Z","timestamp":1757219779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03176-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3176"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03176-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Chulabhorn Research Institute Ethics Committee (EC 099\/2566).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed and written consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1299"}}